Beam Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-848
Closed -$660K 128
2024
Q1
$660K Sell
848
-475
-36% -$338K 0.4% 48
2023
Q4
$771K Sell
1,323
-1
-0.1% -$584 0.49% 43
2023
Q3
$711K Buy
1,324
+167
+14% +$86.1K 0.51% 43
2023
Q2
$543K Buy
1,157
+25
+2% +$10.5K 0.38% 49
2023
Q1
$389K Sell
1,132
-5
-0.4% -$1.69K 0.39% 59
2022
Q4
$416K Buy
1,137
+2
+0.2% +$709 0.43% 57
2022
Q3
$367K Sell
1,135
-3
-0.3% -$951 0.41% 64
2022
Q2
$369K Hold
1,138
0.41% 65
2022
Q1
$326K Sell
1,138
-8
-0.7% -$2.06K 0.37% 62
2021
Q4
$317K Sell
1,146
-451
-28% -$114K 0.36% 65
2021
Q3
$369K Buy
1,597
+40
+3% +$9.87K 0.32% 91
2021
Q2
$357K Buy
1,557
+17
+1% +$3.42K 0.31% 89
2021
Q1
$288K Buy
1,540
+168
+12% +$32.9K 0.26% 94
2020
Q4
$232K Buy
+1,372
New +$205K 0.22% 110

Other funds holding LLY

Beam Wealth Advisors's LLY Position: Q2 2024 in Review

Beam Wealth Advisors sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 848 shares — an estimated $660K sold.

Beam Wealth Advisors first reported a position in LLY in Q4 2020 and held it in 14 quarters. The position peaked at $771K in Q4 2023. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Beam Wealth Advisors reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Beam Wealth Advisors sold 848 Eli Lilly shares in Q2 2024, an estimated $660K.
  • Beam Wealth Advisors first reported a position in Eli Lilly in Q4 2020 and held it in 14 quarters.
  • Beam Wealth Advisors's Eli Lilly position peaked at $771K in Q4 2023.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Beam Wealth Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.